# A Study of JNJ-64281802 in Participants With Confirmed Dengue Fever

> **NCT04906980** · PHASE2 · TERMINATED · sponsor: **Janssen Research & Development, LLC** · enrollment: 5 (actual)

## Conditions studied

- Dengue

## Interventions

- **DRUG:** JNJ-64281802
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04906980
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-01-24
- **Primary completion:** 2022-09-24
- **Final completion:** 2023-03-21
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Feasibility of enrollment impacted by COVID
- **Last updated:** 2024-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04906980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04906980, "A Study of JNJ-64281802 in Participants With Confirmed Dengue Fever". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04906980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*